Lincoln Pharmaceuticals Clarifies Identical Standalone Consolidated Results

Lincoln Pharmaceuticals Ltd. responds to NSE query dated 07-Jan-2026 regarding its Q2 FY25 financial results submission.
Company clarifies that standalone and consolidated P&L figures are identical due to subsidiary having no financial transactions.
Financial results were originally published on 13-Nov-2025 for the quarter ended 30-Sep-2025.
Compliance officer Trusha Shah provides explanation citing SEBI format requirements for financial reporting.